This integrated process statement relates to the document 'Medicines optimisation: key therapeutic topics' (hereafter referred to as key therapeutic topics). It has been produced to explain how key therapeutic topics are developed. It provides an overview of the key process and principles, and describes all stages of the development of key therapeutic topics. These procedures are designed to ensure that a robust, quality-assured document is developed in an open, transparent and timely way, with appropriate input from key groups. This process statement uses the NICE Implementation Support Tool process as an overarching guide to the principles of its development.
http://ift.tt/2q4O70B
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Τετάρτη 10 Μαΐου 2017
Medicines Optimisation: Key Therapeutic Topics – Integrated Process Statement [Internet].
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου